「股神」巴菲特透露埃布尔为巴郡接班人选
《CNBC》报道,「股神」巴菲特旗下投资旗舰巴郡(Berkshire Hathaway)(BRK.A.US)(BRK.B.US)行政总裁的继任人选,为现年58岁,负责管理巴郡非保险业务的巴郡副主席埃布尔(Greg Abel)。现年69岁负责巴郡保险业务的副主席Ajit Jain为Abel的接替人选。
现年97岁的巴郡副主席芒格於股东会上回应有关巴郡是否难以管理的提问时表示,埃布尔会承继巴郡的企业文化,引发外界猜测现年90岁的巴郡主席兼行政总裁巴菲特的继任人选已定。《CNBC》报道指,他们已从巴郡方面确认有关揣测正确。(fc/W)~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.